Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Parenteral Drug Association
BETHESDA, Md., May 6, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced today that it has confirmed the participation of four experts from the U.S. FDA in the upcoming 2014 PDA/FDA Virus and TSE Safety Conference, June 12-13, 2014, at the Hyatt Regency Hotel, Bethesda, Maryland.
The four U.S. FDA experts represent the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER):
"PDA has partnered with the U.S. FDA for nearly a decade to hold conferences and workshops on this critical topic for manufacturers of biotech drug products," said PDA President Richard Johnson. "This year's conference will extensively cover risk mitigation strategies to avoid contamination in biomanufacturing."
FDA's interest in the subject is exemplified by Kurt Brorson's participation not only as a speaker, but as a Co-Chair of the Program Planning Committee. He will provide the U.S. regulatory position on virus and TSE safety during the opening plenary session and another talk on the different regulatory expectations at the clinical and commercial development phases.
Dr. Gregori will discuss reference materials for CJD and vCJD infectivity. Dr. Khan, who also serves on the program planning committee, will discuss advanced virus detection technologies for the evaluation of cell substrates. CDER's Lute will discuss the risks of virus breakthrough in filters and mitigation strategies.
For more information, including press registration, go to www.pda.org.
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. Go http://www.pda.org/footer/about-pda to learn more.
Media Inquiries: Walt Morris, 301-656-5900, x. 148; email@example.com
©2012 PR Newswire. All Rights Reserved.